Views for Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
Total visits
views | |
---|---|
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved. | 272 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 1 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Wiehe_Kevin_2014.pdf | 521 |
Wiehe_Kevin_2014.pdf(legacy) | 74 |
Top country views
views | |
---|---|
United States | 120 |
South Africa | 48 |
Sweden | 26 |
Germany | 15 |
Netherlands | 10 |
Vietnam | 7 |
Finland | 5 |
Ireland | 5 |
India | 4 |
Russia | 4 |
Singapore | 3 |
China | 2 |
France | 2 |
Iran | 2 |
Pakistan | 2 |
Brazil | 1 |
Canada | 1 |
Top city views
views | |
---|---|
Ashburn | 58 |
Johannesburg | 20 |
Hanoi | 7 |
Des Moines | 6 |
Dublin | 5 |
Andover | 4 |
Bengaluru | 3 |
Pretoria | 3 |
Washington | 3 |
Karachi | 2 |
Santa Clara | 2 |
Seattle | 2 |
Singapore | 2 |
Tzaneen | 2 |
Durban | 1 |
Heidelberg | 1 |
Las Vegas | 1 |
Moscow | 1 |
Mumbai | 1 |
Secaucus | 1 |
Stellenbosch | 1 |
Sunnyside | 1 |
São Paulo | 1 |
Tehran | 1 |